Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors

NCT01910597 is registered in ClinicalTrials.gov with Prince of Songkla University as lead sponsor.

NCT NCT01910597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01910597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors
Lead sponsor
Prince of Songkla University
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2013
Completion date
April 20, 2016
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors